ARCHIVES

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

NCI Moratorium On New OIG Applications; P01 Funding Steadily Drops

May 1, 1992

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002

Protocol Amendments Required For 98 NCI-Sponsored Trials

October 8, 2010